Commonwealth Equity Services LLC increased its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 8,410.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 347,391 shares of the medical equipment provider's stock after acquiring an additional 343,309 shares during the quarter. Commonwealth Equity Services LLC owned approximately 0.49% of Align Technology worth $46,011,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Bessemer Group Inc. increased its stake in Align Technology by 37.2% in the first quarter. Bessemer Group Inc. now owns 247 shares of the medical equipment provider's stock valued at $43,000 after purchasing an additional 67 shares during the period. Empirical Finance LLC raised its holdings in shares of Align Technology by 2.9% in the second quarter. Empirical Finance LLC now owns 2,570 shares of the medical equipment provider's stock valued at $433,000 after buying an additional 73 shares during the last quarter. First Bank & Trust boosted its stake in shares of Align Technology by 5.0% during the second quarter. First Bank & Trust now owns 1,599 shares of the medical equipment provider's stock worth $270,000 after buying an additional 76 shares during the period. M.E. Allison & CO. Inc. boosted its stake in shares of Align Technology by 1.9% during the second quarter. M.E. Allison & CO. Inc. now owns 4,235 shares of the medical equipment provider's stock worth $714,000 after buying an additional 80 shares during the period. Finally, Isthmus Partners LLC grew its holdings in shares of Align Technology by 3.7% during the third quarter. Isthmus Partners LLC now owns 2,601 shares of the medical equipment provider's stock worth $378,000 after buying an additional 92 shares during the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.
Align Technology Stock Performance
ALGN stock opened at $166.00 on Friday. Align Technology, Inc. has a one year low of $130.23 and a one year high of $200.43. The stock has a market capitalization of $11.89 billion, a PE ratio of 24.16, a price-to-earnings-growth ratio of 1.80 and a beta of 1.74. The company has a fifty day moving average of $150.38 and a 200-day moving average of $168.50.
Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. During the same period in the previous year, the business posted $2.61 earnings per share. The business's revenue was up 1.9% compared to the same quarter last year. Equities analysts forecast that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the company. Piper Sandler dropped their price target on Align Technology from $235.00 to $205.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 21st. Stifel Nicolaus reduced their price objective on Align Technology from $210.00 to $175.00 and set a "buy" rating for the company in a research note on Friday, October 9th. Zacks Research cut Align Technology from a "hold" rating to a "strong sell" rating in a research report on Thursday, October 15th. Wall Street Zen downgraded Align Technology from a "buy" rating to a "hold" rating in a research note on Saturday, October 24th. Finally, Evercore lowered Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 target price on the stock. in a report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Align Technology presently has an average rating of "Moderate Buy" and a consensus target price of $193.08.
Read Our Latest Stock Analysis on ALGN
Align Technology Profile
(
Free Report)
Align Technology, Inc develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning.
Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Headquartered in Tempe, Arizona, Align serves dental professionals and patients in markets around the world.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.